Literature DB >> 16829594

De novo biosynthetic profiling of high abundance proteins in cystic fibrosis lung epithelial cells.

Harvey B Pollard1, Ofer Eidelman, Catherine Jozwik, Wei Huang, Meera Srivastava, Xia D Ji, Brighid McGowan, Christine Formas Norris, Tsuyoshi Todo, Thomas Darling, Peter J Mogayzel, Pamela L Zeitlin, Jerry Wright, William B Guggino, Eleanore Metcalf, William J Driscoll, Greg Mueller, Cloud Paweletz, David M Jacobowitz.   

Abstract

In previous studies with cystic fibrosis (CF) IB3-1 lung epithelial cells in culture, we identified 194 unique high abundance proteins by conventional two-dimensional gel electrophoresis and mass spectrometry (Pollard, H. B., Ji, X.-D., Jozwik, C. J., and Jacobowitz, D. M. (2005) High abundance protein profiling of cystic fibrosis lung epithelial cells. Proteomics 5, 2210-2226). In the present work we compared the IB3-1 cells with IB3-1/S9 daughter cells repaired by gene transfer with AAV-(wild type)CFTR. We report that gene transfer resulted in significant changes in silver stain intensity of only 20 of the 194 proteins. However, simultaneous measurement of de novo biosynthetic rates with [(35)S]methionine of all 194 proteins in both cell types resulted in the identification of an additional 31 CF-specific proteins. Of the 51 proteins identified by this hybrid approach, only six proteins changed similarly in both the mass and kinetics categories. This kinetic portion of the high abundance CF proteome, hidden from direct analysis of abundance, included proteins from transcription and signaling pathways such as NFkappaB, chaperones such as HSC70, cytoskeletal proteins, and others. Connectivity analysis indicated that approximately 30% of the 51-member hybrid high abundance CF proteome interacts with the NFkappaB signaling pathway. In conclusion, measurement of biosynthetic rates on a global scale can be used to identify disease-specific differences within the high abundance cystic fibrosis proteome. Most of these kinetically defined proteins are unaffected in expression level when using conventional silver stain analysis. We anticipate that this novel hybrid approach to discovery of the high abundance CF proteome will find general application to other proteomic problems in biology and medicine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16829594     DOI: 10.1074/mcp.M600091-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  19 in total

Review 1.  Redox balance in cystic fibrosis.

Authors:  Assem G Ziady; Jason Hansen
Journal:  Int J Biochem Cell Biol       Date:  2014-03-20       Impact factor: 5.085

Review 2.  Genetic variation and clinical heterogeneity in cystic fibrosis.

Authors:  Mitchell L Drumm; Assem G Ziady; Pamela B Davis
Journal:  Annu Rev Pathol       Date:  2011-10-17       Impact factor: 23.472

3.  β-arrestin-2 regulation of the cAMP response element binding protein.

Authors:  Mary E Manson; Deborah A Corey; Sharon M Rymut; Thomas J Kelley
Journal:  Biochemistry       Date:  2011-06-15       Impact factor: 3.162

4.  Ubiquitin C-terminal hydrolase-L1 protects cystic fibrosis transmembrane conductance regulator from early stages of proteasomal degradation.

Authors:  Mark J Henderson; Neeraj Vij; Pamela L Zeitlin
Journal:  J Biol Chem       Date:  2010-02-10       Impact factor: 5.157

Review 5.  Applications of proteomic technologies for understanding the premature proteolysis of CFTR.

Authors:  Mark J Henderson; Om V Singh; Pamela L Zeitlin
Journal:  Expert Rev Proteomics       Date:  2010-08       Impact factor: 3.940

Review 6.  Emergent properties of proteostasis in managing cystic fibrosis.

Authors:  William E Balch; Daniela M Roth; Darren M Hutt
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-02-01       Impact factor: 10.005

7.  Defective CFTR increases synthesis and mass of sphingolipids that modulate membrane composition and lipid signaling.

Authors:  Hiroko Hamai; Fannie Keyserman; Lynne M Quittell; Tilla S Worgall
Journal:  J Lipid Res       Date:  2009-01-14       Impact factor: 5.922

8.  Chemical rescue of deltaF508-CFTR mimics genetic repair in cystic fibrosis bronchial epithelial cells.

Authors:  Om V Singh; Harvey B Pollard; Pamela L Zeitlin
Journal:  Mol Cell Proteomics       Date:  2008-02-19       Impact factor: 5.911

9.  Gender dependence for a subset of the low-abundance signaling proteome in human platelets.

Authors:  Ofer Eidelman; Catherine Jozwik; Wei Huang; Meera Srivastava; Stephen W Rothwell; David M Jacobowitz; Xiaoduo Ji; Xiuying Zhang; William Guggino; Jerry Wright; Jeffrey Kiefer; Cara Olsen; Nima Adimi; Gregory P Mueller; Harvey B Pollard
Journal:  Hum Genomics Proteomics       Date:  2010-04-13

10.  Chemical and biological folding contribute to temperature-sensitive DeltaF508 CFTR trafficking.

Authors:  Xiaodong Wang; Atanas V Koulov; Wendy A Kellner; John R Riordan; William E Balch
Journal:  Traffic       Date:  2008-07-30       Impact factor: 6.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.